Skip to main navigation Skip to search Skip to main content

Evaluation of O3α-,O21-Di- (N1-methyloxycarbonyl-2, 4-dioxo-5-fluoropyrimidinyl) 17α-hydroxy-5β-pregnan-20-one as a novel potential antiangiogenic codrug

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of O3α-,O21-Di- (N1-methyloxycarbonyl-2, 4-dioxo-5-fluoropyrimidinyl) 17α-hydroxy-5β-pregnan-20-one as a novel potential antiangiogenic codrug'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science